Naloxone: What You Need to Know About Overdose Reversal In the Midst of an Opioid Epidemic

Similar documents
Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Naloxone Standing Order for Opioid Overdose

Opioid Harm Reduction

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

PL CE LIVE: Overdose Prevention with Naloxone Opportunities for Pharmacists May 2015

Protocol For: Personally Furnishing Naloxone. Update Log

How to Save a Life: Naloxone for the Treatment of Opioid Overdose

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City

NALOXONE: HEALTHCARE PROFESSIONALS TRAINING GUIDE FOR ADMINISTRATION AND DISPENSING

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health

Naloxone Administration Training

Pennsylvania DEPARTMENT OF HEALTH

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders

Addressing the Opioid Epidemic Naloxone and its Role in Prevention of Opioid Overdose Death May 24, 2018

POWER TO HELP REVERSE AN OPIOID OVERDOSE

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance

Opiate Overdose Treatment: Naloxone Training Protocol

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE

Revised 16 February, of 7

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017

Pharmacist Directed Opioid Antagonist Dispensing

Substance Misuse and Abuse

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose

Naloxone and Combating the Opioid Epidemic

Drug Class Review: Opioid Reversal Agents

Pharmacist Learning Objectives

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Anyone Can Become Addicted. Anyone.

Prescribing Naloxone to Patients for Overdose Reversal

Braintree Public Schools

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

Naloxone Opioid Rescue Kits. Aaron Kochar, JD

????? PL CE LIVE Special Edition: Overdose Prevention with Naloxone Opportunities for Pharmacists. Objectives. Questions We ll Answer Today

Substance Misuse and Abuse

Opioid Use Disorders &Medication Treatment

First Responder Naloxone Grant Webinar

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89

Dosage. Hospira Mylan Amphastar Amphastar syringe Teleflex (nasal adapter) 0.4 mg/ml 4 mg/10 ml. 1mg/mL (2mg/2mL) Nov (b)(2) Narcan Nasal

Naloxone (Narcan) Initiatives and the Court System

Clinical Policy: Naloxone (Evzio) Reference Number: CP.PMN.139 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer,

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine

The Use of Naloxone in Workers Compensation. A Workers Compensation Continuing Education Course

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate

Calvert County Health Department Overdose Education and Naloxone Training

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

2/20/2017 NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE DISCLOSURES LEARNING OBJECTIVES

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences

Management of Suspected Opioid Overdose With Naloxone by EMS Personnel

PATIENT GROUP DIRECTION (PGD)

Opioid Overdose Education and Naloxone Distribution

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region

AN OVERVIEW OF THE PRESENTATION AND TREATMENT OF OPIOID OVERDOSE

A Conversation on Fentanyl. School District 22 VERNON

Overdose Prevention, Recognition & Response Education Train-the-Trainer

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Naloxone in Schools. Training for School Staff

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

Welcome to the Opioid Overdose Prevention Project

Opioid Safety: Focus on Furnishing Naloxone A GUIDE FOR CALIFORNIA COMMUNITY PHARMACISTS

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

Disclosure. State of Connecticut Naloxone Training Program. Introduction. Objectives. Background. Epidemiology 8/28/2018

Safe Practices and Action Items

A Bill Regular Session, 2015 SENATE BILL 880

Opioids and Overdose 2017

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018

Opioid Safety: Focus on Furnishing Naloxone

Opioids 101. Washington Prevention Summit. Alison Newman, MPH November 6, 2018

Medical Directive. Medical Director: Date Revised: January 1, Executive Director: Date Revised: January 1, 2019

Opioids: Public Health Crisis Local Solutions: National Epidemic

PHYSICIAN COMPETENCY FOR ADULT DEEP SEDATION (Ages 14 and older)

Sierra Sacramento Valley EMS Agency

Naloxone Opioid Overdose Reversal Collaborative Drug Therapy Agreement

Bystander Naloxone Training Saves Lives

Drug Overdose Prevention Program (DOPP)

SULLIVAN COUNTY Drug Abuse Prevention Task Force

Slide 1. Slide 2. Slide 3

NALOXONE (NARCAN) POLICY

ADMINISTRATIVE REQUIREMENT MANUAL EFFECTIVE DATE

DECEMBER 7, 2017 THE OPIOID EPIDEMIC & THE UNIVERSITY S RESPONSE

Transcription:

Naloxone: What You Need to Know About Overdose Reversal In the Midst of an Opioid Epidemic Kyle Troksa, Pharm.D., AE-C PGY1 Resident Community Medical Center March 4th, 2018

Conflicts of Interest No conflicts of interest to disclose Accolades Sherrill Brown, Pharm.D., DVM, BCPS University of Montana Skaggs School of Pharmacy Community Medical Center

Objectives 1. Assess scenarios in which naloxone may be administered or prescribed and how to educate patients and providers about its use 2. Analyze similarities and differences amongst naloxone products, resources regarding their use, and current/future applications

Pre-Question #1 What is the mechanism of action of naloxone and common side effects associated with its use? A. Non-competitive opioid antagonist / agitation, hypotension, tachycardia B. Competitive, partial opioid agonist / sedation, hypertension, bradycardia C. Competitive opioid antagonist / agitation, hypertension, tachycardia D. Non-competitive, full opioid agonist / sedation, hypotension, bradycardia

Pre-Question #2 You are the first responder to what was called in as an overdose. The patient is lying on the ground, has constricted pupils, slurred speech, normal breathing and responds to your questions. What is an appropriate action to take? A. Administer one dose of IN naloxone B. Administer two sequential naloxone doses ASAP C. Call EMS and monitor patient for worsening symptoms D. Call law enforcement to arrest patient

Pre-Question #3 A patron comes to you concerned that they will have legal repercussions for calling 911 for their friend who recently overdosed on opioids. What would be your best response? A. Find a good lawyer B. You are covered under the Good Samaritan Law C. Talk to your state representative D. Discuss the matter with your friend first to see if they want to press charges

Pre-Question #4 How soon after the first naloxone dose is given can another be administered if no response? A. 2-5 minutes B. 7-10 minutes C. 12-15 minutes D. 17-20 minutes E. 27-30 minutes

Pre-Question #5 A Russian speaking patient with no health insurance is requesting a recommendation for naloxone product to treat opioid overdose for her mother in the event it is needed. What is the best product to recommend? A. Intranasal Spray B. Intranasal Syringe C. Intramuscular Autoinjector D. A or B E. B or C

Agenda What is the landscape of the opioid epidemic? What is naloxone and its role in therapy? What are the differences in naloxone products? Who can give or receive naloxone? How do you administer naloxone? What are the access laws? What are resources available to providers/patients?

The Opioid Epidemic- Global

The Opioid Epidemic- National 115 Americans die daily from opioid overdose Economic burden: $78.5 Billion annually 2015: 33,000 deaths, 2M opioid related substance use disorders (likely more) 80% of people who use heroin tend to first abuse prescription opioids Epidemic designation from President Trump in 2017 drugabuse.gov

The Opioid Epidemic- National https://www.cdc.gov/mmwr/volumes/66/ss/ss6619a1.htm?s_cid=ss6619a1_w

The Opioid Epidemic- National https://www.cdc.gov/mmwr/volumes/66/ss/ss6619a1.htm?s_cid=ss6619a1_w

This image cannot currently be displayed. https://www.cdc.gov/drugoverdose/images/data/opioiddeathsbytypeus.png

This image cannot currently be displayed. https://drugabuse.com/wp-content/uploads/1annualdeaths_animated.gif

The Opioid Epidemic- Montana This image cannot currently be displayed. Not as bad as national average Between 2000 and 2015, 700 people in MT died of overdoses Pain protocols and limiting discharge opioids could be contributing to benefit Still room for improvement http://nbcmontana.com/news/local/statewide-efforts-aim-to-combat-opioid-epidemic

Naloxone Brand names: Narcan, Evzio Mechanism of Action: competitive, pure opioid antagonist (mainly targets μ-opioid receptors) Onset- 2-5 min Duration- 30-120 min Absorption- IN, IM, SC, IV Distribution- weakly albumin bound, crosses BBB Metabolism- hepatic (glucuronidation) Excretion- urine Lexicomp

This image cannot currently be displayed. Harm Reduction Coalition

Naloxone Adverse reactions (immediate withdrawal): HTN, tachycardia, agitation, dizziness, headache, irritability, seizure, hot flash, abdominal cramps, vomiting, muscle spasm/pain, yawning Injection site reaction Pregnancy risk factor: C (crosses placenta) Breastfeeding: unknown if present in breast milk (lipophilic, so likely) Lexicomp

prescribetoprevent.org

This image cannot currently be displayed. prescribetoprevent.org

Shelf Life Store at RT (59 F-77 F), excursions 39 F-104 F allowed for up to 24 hours 12-18 months (if stored properly, can use until expiration date) Once naloxone vial/amp is inserted into syringe, expires in 2 weeks Monitor expiration date- as last resort, can use expired product, but will likely not be as effective Naloxone Package Insert https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208411lbl.pdf

Signs of an overdose HIGH OVERDOSE Pupils constricted Muscles relaxed Responsive to stimulus Pruritus (scratch at skin) Slurred speech Harm Reduction Coalition Awake, but unable to talk Limp body Pale skin Cyanosis Respiratory depression Bradycardia Choking sounds Vomiting Loss of consciousness Unresponsive to outside stimulus

This image cannot currently be displayed. prescribetoprevent.org

Who can access or administer naloxone Law enforcement Emergency departments Parents/siblings/friends Firefighters School administration Senior centers Military personnel etc. This image cannot currently be displayed. https://www.substance.com/wp-content/uploads/2014/04/stoughton2.png

Approach to Treating an Overdosed Patient SCARE ME: Stimulation Call 911 Airway Rescue Breathing Evaluate the Situation Muscular Injection (or intranasal) Evaluate Again This image cannot currently be displayed. Harm Reduction Coalition http://cdn.ahchealthenews.com/wp-content/uploads/2016/05/naloxone-reverses-opioid-overdose-saves-lives.jpg

Administration- Intranasal Spray How supplied: 4 mg/0.1 ml 2 pack single spray device Sig: Spray entire contents of device into 1 nostril upon signs of opioid overdose. Call 911 May repeat x1 in other nostril This image cannot currently be displayed. CPNP Naloxone Access Guideline

This image cannot currently be displayed. Administration- Intranasal Spray Narcan Package Insert

Administration- Intranasal Syringe How supplied: 2 mg/2 ml 2 pack syringes Also need Rx for atomizer No. 2 Sig: One spray into each nostril upon signs of opioid overdose. Call 911 May repeat x1. This image cannot currently be displayed. CPNP Naloxone Access Guideline

Administration- Intranasal Syringe http://prescribetoprevent.org/patient-education/videos/ CPNP Naloxone Access Guideline

Administration- Intramuscular Vials How supplied: 0.4 mg/ml 2 pack single dose vial Need Rx for 3 ml x 25G 1 in. No. 2 Sig: Inject 1 ml IM upon signs of opioid overdose. Call 911 May repeat x1. This image cannot currently be displayed. CPNP Naloxone Access Guideline

Administration- Intramuscular Vials CPNP Naloxone Access Guideline

Administration- Intramuscular Auto Injector How supplied: 0.4 mg/0.4 ml 2 pack Sig: Inject IM into outer thigh upon signs of opioid overdose. Listen to English prompts--hold in place for 5 seconds. Call 911 May repeat x1. CPNP Naloxone Access Guideline

Administration- Intramuscular Auto Injector This image cannot currently be displayed. EVZIO Package Insert

Insurance Coverage Cost: Intranasal spray- $75.00 Intranasal syringe- $39.60 Intramuscular vials- $18.71 Intramuscular autoinjector- $2,250.00 Coverage: CMS and private plans will pay for naloxone. Atomizer typically not covered (provided free or $10 for 2 atomizers). CPNP Naloxone Access Guideline

Access Laws Good Samaritan Laws MT-HB 333: Help Save Lives From Overdose Act Immunity from legal prosecution for calling for help Standing Orders (to be discussed by Dr. John Douglas) Allows for increased access to naloxone without prescription Liability protection/third party administration: Protects prescriber, pharmacist, and naloxone administrator CPNP Naloxone Access Guideline

Resources https://www.drugabuse.gov/ http://prescribetoprevent.org/ https://www.cdc.gov/drugoverdose/index.html https://www.hhs.gov/opioids/about-the-epidemic/ https://www.samhsa.gov/ CPNP Naloxone Access Guide Project Lazarus Community Toolkit

Resources Drug Take-back Days 1-2 times per year- patients can bring unused/expired medications for disposal Rx drop-boxes Missoula Police Department Granite Pharmacy Other takeback centers: https://dojmt.gov/consumer/prescriptiondrugabuse/rxdropbox-locations

Post-Question #1 What is the mechanism of action of naloxone and common side effects associated with its use? A. Non-competitive opioid antagonist / agitation, hypotension, tachycardia B. Competitive, partial opioid agonist / sedation, hypertension, bradycardia C. Competitive opioid antagonist / agitation, hypertension, tachycardia D. Non-competitive, full opioid agonist / sedation, hypotension, bradycardia

Post-Question #2 You are the first responder to what was called in as an overdose. The patient is lying on the ground, has constricted pupils, slurred speech, normal breathing and responds to your questions. What is an appropriate action to take? A. Administer one dose of IN naloxone B. Administer two sequential naloxone doses ASAP C. Call EMS and monitor patient for worsening symptoms D. Call law enforcement to arrest patient

Post-Question #3 A patron comes to you concerned that they will have legal repercussions for calling 911 for their friend who recently overdosed on opioids. What would be your best response? A. Find a good lawyer B. You are covered under the Good Samaritan Law C. Talk to your state representative D. Discuss the matter with your friend first to see if they want to press charges

Post-Question #4 How soon after the first naloxone dose is given can another be administered if no response? A. 2-5 minutes B. 7-10 minutes C. 12-15 minutes D. 17-20 minutes E. 27-30 minutes

Post-Question #5 A Russian speaking patient with no health insurance is requesting a recommendation for naloxone product to treat opioid overdose for her mother in the event it is needed. What is the best product to recommend? A. Intranasal Spray B. Intranasal Syringe C. Intramuscular Autoinjector D. A or B E. B or C

Preguntas? This image cannot currently be displayed.